
Is Integra LifeSciences (IART) stock Halal?
Verdict for Integra LifeSciences (IART): not Shariah compliant (FAIL). Screened October 2026 under AAOIFI Shariah Standard No. 21. Business activity: pass. Non-permissible income: pass. Interest-bearing investments: pass. Interest-bearing debt: fail. Preference shares: pass. Dividend purification factor: not applicable. Next review: November 2026.
Integra LifeSciences is a prominent company in the medical device field, focused on providing innovative solutions for patients and healthcare professionals globally. Known for its comprehensive portfolio, Integra LifeSciences develops, manufactures, and markets medical devices used primarily in neurosurgery, reconstructive surgery, and regenerative medicine. The company's offerings include a variety of implants, devices, and instruments designed to improve surgical procedures and outcomes. For Muslim investors, though, the most pressing question is simpler: is Integra LifeSciences a Halal investment?
Is Integra LifeSciences Shariah compliant?
No. In the October 2026 screening Integra LifeSciences (IART) does not pass AAOIFI screening: it fails the interest-bearing debt screen. Medicines and medical devices are permissible, and healthcare companies like Integra LifeSciences usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.
Does Integra LifeSciences pass the business activity test?
The activity screen is only part of the picture this month: Integra LifeSciences currently fails the interest-bearing debt screen, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.
Is Integra LifeSciences' income Halal?
Yes, within AAOIFI's tolerance. Integra LifeSciences' income from non-permissible sources stays below 5% of revenue in the October 2026 screening.
Does Integra LifeSciences meet AAOIFI's debt and investment ratio requirements?
Not in full. Interest bearing debt currently exceeds the 30% cap, measured against a market capitalisation of $1.27B (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.
Why do other halal screeners show a different verdict for Integra LifeSciences?
Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.
Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.
New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance










